IDO (2 vs. 0–1) expression and the nodal status (pN0 and pN+) were independent predictors of cancer-specific survival in the multivariate analysis, but sex (male and female), age (<65 and ≥65 years), and grading (G1/2 and G3) were not (see Table 5). Here, IDO1 is linked to cancer.